We're delighted to announce a new partnership between Great Ormond Street Hospital’s Learning Academy and Middlesex University supporting academic education and career development for paediatric healthcare professionals.
Great Ormond Street Hospital was the setting for the announcement of a new Children and Young People Cancer Taskforce as part of the World Cancer awareness day.
Today on Wednesday 14 February, GOSH is celebrating its 172nd birthday. With 2024 being a leap year, we wanted to look back at some of the leaps that we have made in medical science over the past 172 years
Over a number of years, GOSH have been gradually moving clinical services out of the Frontage Building so that later in 2024, it can be deconstructed, creating space for our new Children’s Cancer Centre to be built.
With five children in the UK diagnosed with cancer each day and 1400 children treated at GOSH each year (2021/22), our nursing, physiotherapy and dietetics team have come together with GOSH Charity to mark this important day with patients and families.
The main entrance on Great Ormond Street is now closed and the new entrance can now be found at The Morgan Stanley Clinical Building, on Guilford Street. This is the best entrance for most people with an appointment or admission in the main hospital.
Today, GOSH has launched its new Patient Safety Incident Reporting Plan (PSIRP). This plan outlines how we as an organisation will look at patient safety incidents.
To celebrate Rare Disease Day we invited patients and their families to try out 13 different hands-on and interactive fun and educational science and research activities for children and adults.
We're delighted to announce that Professor Dame Helen Cross and Professor Mark Peters have been named NIHR Senior Investigators in this year’s prestigious award list, making them among the most prominent and prestigious researchers funded by the NIHR.
Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.
A cheap and simple test, being developed with funding from the British Heart Foundation (BHF), will allow quick and safe monitoring in children with arrhythmogenic cardiomyopathies (ACM).
The first-ever targeted treatment for brain tumours in children has been approved for NHS patients, following decades of research by a Great Ormond Street consultant.
